vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). COMSCORE, INC. runs the higher net margin — 3.2% vs -38.1%, a 41.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -1.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 3.8%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
PRCT vs SCOR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $93.5M |
| Net Profit | $-31.6M | $3.0M |
| Gross Margin | 64.9% | 41.0% |
| Operating Margin | -4.1% | 7.0% |
| Net Margin | -38.1% | 3.2% |
| Revenue YoY | 20.2% | -1.5% |
| Net Profit YoY | -27.9% | -3.7% |
| EPS (diluted) | $-0.56 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $93.5M | ||
| Q3 25 | $83.3M | $88.9M | ||
| Q2 25 | $79.2M | $89.4M | ||
| Q1 25 | $69.2M | $85.7M | ||
| Q4 24 | $68.2M | $94.9M | ||
| Q3 24 | $58.4M | $88.5M | ||
| Q2 24 | $53.4M | $85.8M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | $3.0M | ||
| Q3 25 | $-21.4M | $453.0K | ||
| Q2 25 | $-19.6M | $-9.5M | ||
| Q1 25 | $-24.7M | $-4.0M | ||
| Q4 24 | $-18.9M | $3.1M | ||
| Q3 24 | $-21.0M | $-60.6M | ||
| Q2 24 | $-25.6M | $-1.7M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | 41.0% | ||
| Q3 25 | 64.8% | 40.6% | ||
| Q2 25 | 65.4% | 40.6% | ||
| Q1 25 | 63.9% | 39.6% | ||
| Q4 24 | 64.0% | 42.4% | ||
| Q3 24 | 63.2% | 41.2% | ||
| Q2 24 | 59.0% | 39.5% |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 7.0% | ||
| Q3 25 | -27.8% | 1.9% | ||
| Q2 25 | -28.0% | -1.9% | ||
| Q1 25 | -39.7% | -2.4% | ||
| Q4 24 | -28.9% | 4.1% | ||
| Q3 24 | -38.4% | -67.4% | ||
| Q2 24 | -50.3% | -2.2% |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | 3.2% | ||
| Q3 25 | -25.7% | 0.5% | ||
| Q2 25 | -24.7% | -10.6% | ||
| Q1 25 | -35.8% | -4.7% | ||
| Q4 24 | -27.6% | 3.3% | ||
| Q3 24 | -35.9% | -68.5% | ||
| Q2 24 | -48.0% | -2.0% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $9.50 | ||
| Q3 25 | $-0.38 | $-0.86 | ||
| Q2 25 | $-0.35 | $-2.73 | ||
| Q1 25 | $-0.45 | $-1.66 | ||
| Q4 24 | $-0.34 | $-0.47 | ||
| Q3 24 | $-0.40 | $-12.79 | ||
| Q2 24 | $-0.50 | $-1.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $23.6M |
| Total DebtLower is stronger | $51.7M | $41.5M |
| Stockholders' EquityBook value | $347.7M | $111.4M |
| Total Assets | $487.1M | $407.7M |
| Debt / EquityLower = less leverage | 0.15× | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $23.6M | ||
| Q3 25 | $294.3M | $26.7M | ||
| Q2 25 | $302.7M | $26.0M | ||
| Q1 25 | $316.2M | $31.0M | ||
| Q4 24 | $333.7M | $29.9M | ||
| Q3 24 | $196.8M | $20.0M | ||
| Q2 24 | $214.1M | $14.7M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | $41.5M | ||
| Q3 25 | $51.6M | $41.4M | ||
| Q2 25 | $51.5M | $41.3M | ||
| Q1 25 | $51.5M | $41.3M | ||
| Q4 24 | $51.5M | $41.2M | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $111.4M | ||
| Q3 25 | $380.3M | $-26.3M | ||
| Q2 25 | $385.8M | $-21.7M | ||
| Q1 25 | $389.2M | $-13.5M | ||
| Q4 24 | $402.2M | $-8.3M | ||
| Q3 24 | $241.2M | $-2.7M | ||
| Q2 24 | $251.8M | $45.8M |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $407.7M | ||
| Q3 25 | $511.5M | $406.9M | ||
| Q2 25 | $513.1M | $415.9M | ||
| Q1 25 | $519.4M | $421.5M | ||
| Q4 24 | $534.0M | $430.2M | ||
| Q3 24 | $374.1M | $412.5M | ||
| Q2 24 | $374.4M | $474.1M |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | 0.37× | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.2M |
| Free Cash FlowOCF − Capex | — | $2.9M |
| FCF MarginFCF / Revenue | — | 3.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | — | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $3.2M | ||
| Q3 25 | $-6.6M | $9.5M | ||
| Q2 25 | $-15.0M | $932.0K | ||
| Q1 25 | $-17.0M | $9.1M | ||
| Q4 24 | $-32.4M | $-10.0M | ||
| Q3 24 | $-18.8M | $12.5M | ||
| Q2 24 | $-15.7M | $8.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | $2.9M | ||
| Q3 25 | $-9.5M | $9.4M | ||
| Q2 25 | $-17.8M | $787.0K | ||
| Q1 25 | $-18.8M | $8.7M | ||
| Q4 24 | $-33.6M | $-10.3M | ||
| Q3 24 | $-19.0M | $12.4M | ||
| Q2 24 | $-16.8M | $8.5M |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | 3.1% | ||
| Q3 25 | -11.4% | 10.5% | ||
| Q2 25 | -22.5% | 0.9% | ||
| Q1 25 | -27.2% | 10.1% | ||
| Q4 24 | -49.2% | -10.8% | ||
| Q3 24 | -32.6% | 14.0% | ||
| Q2 24 | -31.4% | 10.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 0.3% | ||
| Q3 25 | 3.4% | 0.1% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 2.7% | 0.4% | ||
| Q4 24 | 1.7% | 0.2% | ||
| Q3 24 | 0.4% | 0.1% | ||
| Q2 24 | 2.0% | 0.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
